Cargando…
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Chronic liver disease (CLD) is a growing health concern which accounts for two million deaths per year. Obesity, alcohol overconsumption, and progressive cholestasis are commonly characterized by persistent low-grade inflammation and advancing fibrosis, which form the basis for development of end-st...
Autores principales: | De Muynck, Kevin, Vanderborght, Bart, Van Vlierberghe, Hans, Devisscher, Lindsey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616442/ https://www.ncbi.nlm.nih.gov/pubmed/34831182 http://dx.doi.org/10.3390/cells10112959 |
Ejemplares similares
-
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
por: Vanderborght, Bart, et al.
Publicado: (2020) -
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model
por: Vanderborght, Bart, et al.
Publicado: (2020) -
Rodent models of cholestatic liver disease: A practical guide for translational research
por: Gijbels, Eva, et al.
Publicado: (2021) -
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models
por: Degroote, Helena, et al.
Publicado: (2021) -
NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
por: Vandierendonck, Astrid, et al.
Publicado: (2021)